Genomics and precision medicine and their impact on endocrinology
- PMID: 37014294
- PMCID: PMC10305474
- DOI: 10.1530/EC-23-0106
Genomics and precision medicine and their impact on endocrinology
Conflict of interest statement
The author reports funding from the ELPEN, Pfizer, Lundbeck, and Sterotherapeutics pharmaceuticals, Human Longevity, Inc., and holds patents on the PRKAR1A, PDE11A and GPR101 genes and functions.
References
Publication types
LinkOut - more resources
Full Text Sources